1. Home
  2. ABVX vs HBM Comparison

ABVX vs HBM Comparison

Compare ABVX & HBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • HBM
  • Stock Information
  • Founded
  • ABVX 2013
  • HBM 1927
  • Country
  • ABVX France
  • HBM Canada
  • Employees
  • ABVX N/A
  • HBM N/A
  • Industry
  • ABVX
  • HBM Metal Mining
  • Sector
  • ABVX
  • HBM Basic Materials
  • Exchange
  • ABVX Nasdaq
  • HBM Nasdaq
  • Market Cap
  • ABVX 5.3B
  • HBM 5.4B
  • IPO Year
  • ABVX N/A
  • HBM N/A
  • Fundamental
  • Price
  • ABVX $83.31
  • HBM $13.40
  • Analyst Decision
  • ABVX Strong Buy
  • HBM
  • Analyst Count
  • ABVX 8
  • HBM 0
  • Target Price
  • ABVX $90.63
  • HBM N/A
  • AVG Volume (30 Days)
  • ABVX 1.1M
  • HBM 5.0M
  • Earning Date
  • ABVX 08-11-2025
  • HBM 11-12-2025
  • Dividend Yield
  • ABVX N/A
  • HBM 0.11%
  • EPS Growth
  • ABVX N/A
  • HBM 216.33
  • EPS
  • ABVX N/A
  • HBM 0.72
  • Revenue
  • ABVX $7,073,400.00
  • HBM $2,202,000,000.00
  • Revenue This Year
  • ABVX $25.23
  • HBM $13.79
  • Revenue Next Year
  • ABVX N/A
  • HBM N/A
  • P/E Ratio
  • ABVX N/A
  • HBM $18.54
  • Revenue Growth
  • ABVX N/A
  • HBM 8.31
  • 52 Week Low
  • ABVX $4.77
  • HBM $5.95
  • 52 Week High
  • ABVX $92.91
  • HBM $13.96
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 61.47
  • HBM 68.75
  • Support Level
  • ABVX $82.72
  • HBM $11.62
  • Resistance Level
  • ABVX $86.72
  • HBM $13.96
  • Average True Range (ATR)
  • ABVX 3.94
  • HBM 0.34
  • MACD
  • ABVX -1.81
  • HBM 0.02
  • Stochastic Oscillator
  • ABVX 25.93
  • HBM 76.07

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About HBM Hudbay Minerals Inc. (Canada)

Hudbay Minerals Inc is a Canadian mining company with its operations, property developments, and exploration activities across the United States. The mines that Hudbay operates are located in Manitoba, Canada, Arizona, United States; and Peru. The company is principally focused on the discovery, production, and marketing of base and precious metals. Hudbay produces copper concentrate, which contains copper, gold, and silver, as well as zinc metal. More than half the company's revenue is attributable to the copper business. The company sells copper concentrates to smelters across Asia, America, and Europe, and sells Zinc metal, another source of revenue, to industrial customers across North America.

Share on Social Networks: